Výsledky vyhledávání - "Thomas J. Braun"

The Development, Validation, and Practical Application of an Employee Agility and Resilience Measure to Facilitate Organizational Change

Autor: Rachel L. Frautschy DeMuth, Bryan C. Hayes, Olya A. Taran, Thomas J. Braun

Publikováno v: Industrial and Organizational Psychology. 10:703-723

Traditional change management approaches that focus on linear models and top-down control have proved less than adequate in addressing organizational change within the complexity and speed of today's unprecedented change. Researchers have suggested t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::35c349e64b7446c748f7354e63389a23
https://doi.org/10.1017/iop.2017.79

Zobrazit plný text záznamu

An Alternative Technique for Applying Accession Numbers to Museum Artifacts

Autor: Thomas J. Braun

Publikováno v: Journal of the American Institute for Conservation. 46:91-104

For decades archaeologists and museum professionals have applied accession numbers to artifacts using a variety of methods. A common method has been the hand-numbering technique: a barrier layer is applied, over which the number is written in ink and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f926082826cc788884e7e1096f2a6aff
https://doi.org/10.1179/019713607806112323

Zobrazit plný text záznamu

SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: A southwest oncology group study

Autor: Maha Hussain, Saul E. Rivkin, Craig R. Nichols, Catherine E. Klein, David M. Peereboom, E. David Crawford, Shaker R. Dakhil, Thomas J. Braun, Catherine M. Tangen

Publikováno v: The Prostate. 52:264-268

BACKGROUND Prostate cancer is the most common malignancy in American men, and as many as 70% of those initially treated for localized disease will ultimately progress and be considered candidates to receive therapy for metastatic cancer [Fuks et al.:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b9eb620ebbe8c27f8cccbd831737723
https://doi.org/10.1002/pros.10118

Zobrazit plný text záznamu

Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group

Autor: Michele Baccarani, German A. Gomez, Bayard D. Clarkson, Tura S, Judith E. Robertson, Arturo Pereira, Francisco Cervantes, Ciril Rozman, Thomas J. Braun

Publikováno v: British Journal of Haematology. 87:293-300

SUMMARY. The purposes of the present work were to identify the initial characteristics associated with long-term survival in chronic granulocytic leukaemia (CGL) and to analyse the accuracy of prognostic models in identifying long-term survivors. 813

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::646a86df33f5c470c2fc8e2343c30977
https://doi.org/10.1111/j.1365-2141.1994.tb04912.x

Zobrazit plný text záznamu

Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

Autor: Stanley P. Balcerzak, Stephen K. Williamson, I Gill, M E Marshall, Robert B. Livingston, James K. Weick, Steven M. Grunberg, John Crowley, Thomas J. Braun, T O'Rourke

Publikováno v: Journal of Clinical Oncology. 11:1598-1601

PURPOSE We designed an all-oral regimen of etoposide and cyclophosphamide for use in advanced non-small-cell lung cancer. PATIENTS AND METHODS Eligible patients were chemotherapy-naive and had histologically confirmed assessable or measurable stage I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489beb1bb6a739654a8ae194e7ae6fb8
https://doi.org/10.1200/jco.1993.11.8.1598

Zobrazit plný text záznamu

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group

Autor: Steven M. Grunberg, Stanley P. Balcerzak, Edith A. Perez, Robert B. Livingston, Geoffrey R. Weiss, Ronald B. Natale, Thomas J. Braun, Laura F. Hutchins, Charles W. Taylor, John Crowley, Ralph W. Roach, David R. Gandara, John R. Neefe

Publikováno v: Journal of Clinical Oncology. 11:873-878

PURPOSE To test the concept that cisplatin dose-intensity is important in the treatment of non-small-cell lung cancer (NSCLC), the Southwest Oncology Group (SWOG) performed a randomized trial comparing standard-dose cisplatin (SDCP) 50 mg/m2 days 1 a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a381b948b9591d05db01a10e7d4c645e
https://doi.org/10.1200/jco.1993.11.5.873

Zobrazit plný text záznamu

Evaluation of amonafide in refractory and relapsing multiple myeloma

Autor: John Crowley, Karl H Hanson, Sydney E. Salmon, Michael D. Keppen, Thomas J Braun, John D. Bonnet

Publikováno v: Anti-Cancer Drugs. 2:247-250

This study involved the administration of amonafide intravenously 300 mg/m2 daily times five days every three weeks to 16 refractory and relapsed myeloma patients. Doses were escalated to toxicity. These doses caused severe thrombocytopenia and granu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f22c644c27429296574acb8235d06be1
https://doi.org/10.1097/00001813-199106000-00004

Zobrazit plný text záznamu

A Phase II Trial of Recombinant Tumor Necrosis Factor in Patients with Adenocarcinoma of the Pancreas: A Southwest Oncology Group Study

Autor: Thomas D. Brown, John S. Macdonald, Evan M. Hersh, Thomas J. Braun, Thomas R. Fleming, Phyllis J. Goodman

Publikováno v: Journal of Immunotherapy. 10:376-378

Twenty-two evaluable patients with advanced adenocarcinoma of the pancreas, but without prior chemotherapy or immunotherapy, received recombinant tumor necrosis factor (rTNF). rTNF was given as an intravenous infusion over 30 min daily x 5, every 14

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abbe548df8da6d103dfe2f0c37d7143
https://doi.org/10.1097/00002371-199110000-00010

Zobrazit plný text záznamu

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study

Autor: John Crowley, M O'Rourke, M B Hazuka, Robert B. Livingston, Thomas J. Braun, Paul A. Bunn

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 12(9)

PURPOSE This single-arm phase II trial was designed to evaluate the efficacy and toxicity of continuous-course, high-dose thoracic irradiation (RT) combined with concurrent daily low-dose cisplatin followed by high-dose cisplatin consolidation in pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0caeae650387889480937869913501d
https://pubmed.ncbi.nlm.nih.gov/8083705

Zobrazit plný text záznamu

Death in a hot tub: The physics of heat stroke

Autor: Thomas J. Braun, Albert A. Bartlett

Publikováno v: American Journal of Physics. 51:127-132

High environmental temperature and/or vigorous physical work will tend to cause a person’s body temperature to rise. In an attempt to maintain a normal body temperature of 37°C the body then increases its rate of dissipation of heat by mechanisms

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd2b70696c7702aa55dccfdff68c4636
https://doi.org/10.1119/1.13466

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání